Related Content
November 18, 2011 – An analysis of the TRITON-TIMI 38 trial presented today in an oral session at the American Heart ...
November 18, 2011
November 9, 2011 – PETNET Solutions Inc., a wholly owned subsidiary of Siemens Medical Solutions USA Inc., has entered ...
November 09, 2011
August 18, 2011 — The antiplatelet agent prasugrel (trade name Effient), in combination with aspirin, was associated ...
August 19, 2011
April 1, 2011 – Oral antiplatelet therapy Effient (prasugrel) has been added to the updated clinical practice guidelines ...
April 01, 2011
September 15, 2010 – A study evaluating the level of platelet aggregation achieved after switching from clopidogrel ...
September 15, 2010July 1, 2010 – Two medical companies say they will work with physicians to further investigate ways to manage genetic ...
July 01, 2010January 7, 2010 – Anti-platelet treat with Effient (prasugrel) compared with Plavix (clopidogrel) was more cost ...
January 07, 2010
July 13, 2009 – Daiichi Sankyo Inc. and Eli Lilly and Company said Friday the FDA approved Effient (prasugrel) tablets ...
July 13, 2009February 23, 2009 - Daiichi Sankyo Co. Ltd and Eli Lilly and Co. announced today that the European Commission granted ...
February 23, 2009Jan. 19, 2007 — Daiichi Sankyo Co., Ltd. and Eli Lilly and Co. have announced completion of patient enrollment in their ...
January 18, 2007